Search Patents
  • Patent number: 8679407
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: March 25, 2014
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Ian Gibbons, John Howard, Shaunak Roy, Chengwang Wang, Timothy M. Kemp
  • Patent number: 8435738
    Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
    Type: Grant
    Filed: September 26, 2011
    Date of Patent: May 7, 2013
    Assignee: Theranos, Inc.
    Inventor: Elizabeth Holmes
  • Patent number: 8741230
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Grant
    Filed: October 30, 2006
    Date of Patent: June 3, 2014
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Shaunak Roy, Ian Gibbons, Shize Daniel Qi, Edmond Ku, Chris Todd, Melissa Takahashi, Bruce Johnson, Jeff Fenton, Keith Moravick, Uwe Springborn, Anthony Delacruz
  • Patent number: 8841076
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: September 23, 2014
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Ian Gibbons, Timothy M. Kemp, John Howard, Shaunak Roy
  • Patent number: 8283155
    Abstract: This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow real-time detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: October 9, 2012
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Shaunak Roy, John Howard, Chengwang Wang, Ian Gibbons, Timothy M. Kemp, Shize Daniel Qi
  • Publication number: 20130079236
    Abstract: Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample.
    Type: Application
    Filed: September 26, 2011
    Publication date: March 28, 2013
    Applicant: Theranos, Inc., a Delaware Corporation
    Inventor: Elizabeth Holmes
  • Patent number: 7291497
    Abstract: The invention relates to an ingestible, implantable or wearable medical device comprising a microarray which comprises a bioactive agent capable of interacting with a disease marker biological analyte; a reservoir which comprises at least one therapeutic agent and is capable of releasing the therapeutic agent(s) from the medical device; and a plurality of microchips comprising a microarray scanning device capable of obtaining physical parameter data of an interaction between the disease marker biological analyte with the bioactive agent; a biometric recognition device capable of comparing the physical parameter data with an analyte interaction profile; optionally a therapeutic agent releasing device capable of controlling release of the therapeutic agent from the reservoirs; an interface device capable of facilitating communications between the microarray scanning device, biometric recognition device and the therapeutic agent releasing device; and an energy source to power the medical device.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: November 6, 2007
    Assignee: Theranos, Inc.
    Inventors: Elizabeth A. Holmes, Shaunak Roy, John Howard, Chengwang Wang